2m 2m 2m 2m 2m 2m 2m
TARSUS PHARMA (TARS)
NASDAQ
$59.25-$0.06 (-0.10%)
Price as of Jul 13, 2026 7:56 PM EDT- $2.5BMarket Cap
- 42.81%1-Year Change
- BiotechnologyIndustry
TARSUS PHARMA (TARS)
$59.25-$0.06 (-0.10%)
TARS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $59.31 | ||
Change | +$1.17 (+2.01%) | ||
Open | $58.25 | ||
High | $60.20 | ||
Low | $56.96 | ||
Previous Close | $58.14 | ||
Volume | 1,113,250 | ||
30-Day Average Volume | 1,351,027 | ||
1-Week Change | -11.54% | ||
1-Month Change | -4.26% | ||
1-Year Change | 42.81% | ||
3-Year Change | 238.33% | ||
5-Year Change | 113.88% | ||
Fundamentals | |||
Shares Outstanding | 43.0M | ||
Total Assets | $581.1M | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | $145.4M | ||
Net Income | -$7.0M | ||
Free Cash Flow | -$30.5M | ||
EBIT | -$2.5M | ||
EBITDA | -$2.2M | ||
Net Working Capital | $393.7M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -1,100 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 7 | ||
P/E | -363 | ||
PEG | -20 | ||
Price/Free Cash Flow | -82 | ||
Price/Operating Cash Flow | -101 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue